Oral anticoagulant timing and hospitalization in newly diagnosed nonvalvular atrial fibrillation patients
This study highlights OAC underutilization in NVAF patients and suggests early initiation may lower hospitalization rates. The findings emphasize the need for further research into real-world compliance with OAC guidelines and call for further research to confirm the benefits of early initiation. Personalized management strategies that consider individual patient profiles are recommended.
Authors
- Ning Rosenthal (ORCID: https://orcid.org/0000-0002-3404-3717)
- Laura Curry
- Chendi Cui (ORCID: https://orcid.org/0000-0002-7022-4486)
- Nisha Singh
Institutions
- Bristol-Myers Squibb (Sweden) (SE)
- Premier Research Group (US)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-04-04
- DOI
- https://doi.org/10.3389/fcvm.2025.1522154
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78